Clinical Trial Update: Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan

View source ↗

Summary

A clinical trial update examining aristolochic acid–DNA adducts in urothelial carcinoma patients in Taiwan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Urothelial Carcinoma | Status: UNKNOWN